Human rhinoviruses (HRVs) are a group of small, single-stranded, positive-sense RNA viruses of the genus *Enterovirus* that belong to the family *Picornaviridae*. HRV is one of the most frequent causes of acute respiratory diseases (ARDs) and highly affects the morbidity and mortality of children and infants[@b1][@b2][@b3]. HRV has been known for decades; however, no effective vaccine or drug is available to prevent and cure this infection.

HRV exhibits a high genetic diversity and has been re-classified into three species, namely, HRV-A, HRV-B, and HRV-C. HRV-C is a novel species with a unique phylogenetic position and distinct genomic characteristics[@b4]. Previous studies have shown that HRV-C exhibits a significantly higher genetic diversity than the HRV-A and HRV-B serotypes[@b5][@b6][@b7]. The complete genome set of this virus also confirmed interspecies recombination events in HRV-C evolution[@b8][@b9]. These findings provide evidence that the recently identified HRV-C is not an emerging strain; instead, HRV-C has been present for a long time without being detected[@b10][@b11].

Studies have revealed that HRV-C has been detected in patients with respiratory tract infections worldwide[@b1][@b12][@b13][@b14][@b15][@b16][@b17][@b18][@b19]. Although the clinical manifestations of HRV-C infections vary in different areas[@b4][@b20], this infection is mainly associated with cough and asthma exacerbations[@b2][@b21], acute lower respiratory tract infections, bronchiolitis, and pneumonia, particularly in children[@b4][@b22]. A few studies have shown that HRV-C is possibly more virulent and associated with more severe diseases than HRV-A and HRV-B[@b2][@b4][@b21][@b23][@b24]; however, controversial results have been obtained from other studies[@b8][@b25]. Seasonal patterns of HRV-C infection have been revealed, in which HRV-C incidence reaches its peak in the early fall and late spring in many temperate or subtropical countries and in the rainy season in tropical countries[@b4][@b19][@b25][@b26].

Cross-sectional studies in China have suggested that HRV-C, in combination with HRV-A, is a predominant species associated with acute respiratory illnesses in hospitalized children and adults[@b27][@b28]. However, previous studies were limited by short observation periods, small sample sizes, and inadequate genetic analyses[@b25][@b27][@b29]. These studies were performed before the classification of HRV species as HRV-A and HRV-B was proposed in 2010 and before the later publication of the proposal for HRV-C in 2013[@b30][@b31]. Furthermore, the presence of more than 100 genetically and serologically distinct HRVs and their roles in human illnesses remain unexplored. To provide a timely estimation of HRV circulation and to acquire the exact genetic characteristics of HRVs in China, researchers should continuously monitor HRV infection by using new classification methods.

In the current study, the molecular epidemiology and clinical characteristics of HRV, particularly HRV-C, were investigated by a three-year surveillance study on children with ARD.

Methods
=======

The retrospective study was conducted at the Children\'s Hospital, Chongqing Medical University (CHCMU), Chongqing, China, as a part of a viral surveillance of ARD cases from June 2009 to June 2012. Chongqing is located in a subtropical region; CHCMU is the largest children\'s hospital in southeastern China and serves the population of Sichuan Province and two neighboring provinces. ARD was determined on the basis of an acute disease onset with symptoms of cough, rhinorrhea, dyspnea, and a fever of more than 37.5°C. Children aged \< 14 years who were admitted in respiratory clinics for ARD were recruited in this study. Nasopharyngeal aspirates (NPAs) were collected and subjected to a laboratory analysis. Severe pneumonia was defined as pneumonia plus hypoxemia (at a constant SaO~2~ \< 92% in the air) or an increase in respiratory and pulse rates with clinical evidence of respiratory distress and exhaustion with or without an increase in PaCO~2~ concentrations.

RNA was extracted from each specimen by using QIAamp® MinElute virus spin kits (Qiagen, Hilden, Germany). The cDNA was synthesized using a SuperScript® III first-strand synthesis system for the reverse transcription polymerase chain reaction (RT-PCR; Invitrogen, USA). HRV was detected by PCR, and the amplicons were further sequenced using the primers of 5′-NTR sequences to classify the subtypes of HRV, as described previously[@b32]. The samples were also screened to determine the presence of the influenza virus (A, B, and C), metapneumovirus, respiratory syncytial virus (RSV), parainfluenza virus (types 1--4), and coronaviruses (229E and OC43) by using molecular methods, as described previously[@b33].

The VP4/VP2 coding regions of the HRV-C-positive samples were further amplified and sequenced to identify the HRV type and genetic characteristics, as described in a previous study[@b31]. Primers targeting the VP4/VP2 coding region of HRV (forward, 5′-GGGACCAACTACTTTGGGTGT CCGTGT-3′; reverse, 5′-CACGGACACCCAAAGTAGT-3′) were used. PCR was performed at 95°C for 5 min followed by 40 cycles at 95°C for 30 s, at 60°C for 45 s, at 72°C for 45 s, and at 72°C for 10 min for a final extension.

The genomic sequences were assembled using Lasergene\'s DNA SeqMan software (version 7.1.0, DNA Star Inc., Madison, WI, USA). Available partial HRV-C VP4/VP2 coding region sequences were obtained from GenBank. The alignments were compared, and a phylogenetic tree was constructed using a neighbor-joining method with 1,000 bootstrap pseudoreplicates (MEGA 5). Similarities between the strains were calculated using BioEdit (version 7.13, [www.mbio.ncsu.edu/bioedit/bioedit.html](http://www.mbio.ncsu.edu/bioedit/bioedit.html)).

A standardized questionnaire was designed to obtain the patients\' information from medical records, including demographic characteristics, underlying medical conditions, symptoms and signs, laboratory tests, radiographic findings, sputum culture results, and the disease outcome. Consent was obtained from the guardians of the children. The study protocol was reviewed and approved by the Ethics Review Committee of CHCMU. The study was conducted in accordance with the approved guidelines.

The variables were subjected to descriptive statistics: the continuous variables were summarized as the means and standard deviations or medians and ranges, and the categorical variables were summarized as frequencies and proportions. To determine the differences between groups, we performed chi-square tests, Fisher\'s exact tests, and non-parametric tests or ANOVAs whenever appropriate. A logistic regression analysis was performed to identify the associations between HRV subtypes and severe pneumonia. Odds ratios (ORs) and their 95% confidence intervals (CIs) were estimated using maximum-likelihood methods. A two-sided *P* value of less than 0.05 was considered statistically significant. The statistical analyses were conducted using SAS 9.1.3 (SAS Institute, Cary, North Carolina, USA).

Results
=======

A total of 1,567 NPAs (145 from 2009, 446 from 2010, 698 from 2011, and 278 from 2012) were collected from children aged 1 month to 14 years (median = 9 months). Approximately 66.1% (1036) of these children were male. Furthermore, 223 (14.2%) were HRV positive and aged 1 month to 12 years (median = 8 months), from which 159 (71.3%) were male. The age and gender distributions of the HRV-positive patients were not significantly different from the other patients. According to the 5′-UTR sequences, 54.7% (122/223) of the HRVs detected were HRV-A, 5.4% (12/223) were HRV-B, and 39.9% (89/223) were HRV-C (*P* \< 0.001).

Among the HRV-positive patients, 24.7% (55/223) were affected by single infections and 75.3% (168/223) were co-infected with other viruses, such as RSV (74/223, 33.2%), parainfluenza virus (60/223, 26.9%), and influenza virus (58/223, 26.0%). Co-infection occurred evenly among the three genotypes.

The clinical and epidemiological characteristics of the HRV-positive patients are shown in [Table 1](#t1){ref-type="table"}. The age and gender distributions were comparable between groups with single infections and co-infection. Cough, expectoration, and moist rales were the main clinical manifestations. The clinical manifestations of expectoration and diarrhea were significantly overrepresented in the patients with HRV co-infections than in the patients with HRV single infections ([Table 1](#t1){ref-type="table"}). Severe pneumonia was identified in 31 (13.9%) HRV-infected patients; among these patients, nine exhibited single infections. A similar frequency was obtained in the patients with co-infection. Except for the higher frequencies of cough and moist rales in the patients with HRV-A and HRV-C, all the other clinical manifestations were evenly distributed among the three HRV genotype groups.

The occurrences of wheezing, asthma, and severe pneumonia were further analyzed using multivariate-logistic regression models. In general, HRV infection was significantly associated with wheezing (OR = 1.37, 95% CI = 1.02--1.84) and asthma attacks (OR = 1.68, 95% CI = 1.15--2.45) after considering the effects of age, sex, and the presence of other respiratory viruses. These associations were not observed in the patients with single HRV infections ([Table 2](#t2){ref-type="table"}). The effects of the HRV subtypes on clinical outcomes revealed that HRV-A and HRV-C were more likely associated with asthma using the multivariate logistic regression analysis (OR = 1.68, 95% CI = 1.03--2.74 and OR = 1.89, 95% CI = 1.10--3.27, respectively). Additionally, HRV-C was associated with cough (OR = 1.71, 95% CI = 1.08--2.69). No effects on severe pneumonia were observed from either the single HRV or the co-infected HRV genotypes.

The identified HRV-C was further characterized by constructing a phylogenetic tree using the sequences of the VP4/VP2 coding region from representative subtypes in GenBank. Based on the criteria of the HRV-C subtypes presented by Simmonds et al.[@b30], the 89 HRV-C samples from the study were grouped into 32 HRV-C subtypes ([Figure 1](#f1){ref-type="fig"}). HRV-C2 was the predominant subtype, followed by HRV-C43, HRV-C1, and HRV-C17 ([Figure 2](#f2){ref-type="fig"}). Six HRV-Cs demonstrated less than 90% similarities with 51 HRV gene sequences available in GenBank ([Table 3](#t3){ref-type="table"}, detailed in [Supplementary Table S1](#s1){ref-type="supplementary-material"}). Among these six, CQ4290 (maximum identity, 77.7%), CQ3144-CQ4245 (maximum identity, 83.5%), and CQ4260 (maximum identity, 84.5%) could be designated into novel genotypes and were temporarily named HRV-Cpat52, HRV-Cpat53, and HRV-Cpat54, respectively. Another two strains (CQ5641 and CQ2026) had homologies close to 90% and were accordingly classified as HRV-C2 and HRV-C16, respectively.

Temporally, HRV occurred throughout the whole year and displayed a characteristic biennial outbreak pattern with alternating high and low peaks during the winter and spring seasons, respectively ([Figure 3](#f3){ref-type="fig"}). Independently, HRV-A showed comparable magnitudes of winter and spring peaks, whereas HRV-C demonstrated distinct peaks during the winter, spring, and early summer. Notably, the HRV-C peaks constantly appeared behind the HRV-A peaks at 1--2 month intervals, regardless of the year or season. The seasonal distribution of HRV-B could not be clearly defined because of the low number of positive detections.

Discussion
==========

In this study, HRV-A and HRV-C were identified as the predominant species present in pediatric patients in China for the most recent three years. HRV-C is genetically closer to HRV-A than to HRV-B. The three new lineages of HRV-C that were identified possibly indicate the rapid evolution of HRV-C in China. These findings further substantiate the necessity of continuous surveillance.

In China, HRV was found to circulate among patients with ARDs by retrospective investigation. Jin et al.[@b29] reported a 13.1% HRV detection rate from 406 NPA samples collected from children in Lanzhou from 2006 to 2007, which consisted of 42% HRV-A, 23% HRV-B, and 36% HRV-C species. A study in Hong Kong, China, conducted in 2004--2005 revealed a significantly higher frequency of HRV (29.7%) in pediatric patients with ARDs with the HRV-genotype group composition comparable to the results of the current study (50.4% HRV-A, 41.4% HRV-C, and 8.2% HRV-B)[@b25]. The detection rate of HRV or its subtypes appears to be influenced by detection methods as well as by the spatial and temporal characteristics of detection in various studies.

The seasonality of HRV circulation has been studied previously, with seasonal patterns varying geographically in different countries or regions. The highest HRV-C occurrences are observed during October in America[@b34], fall and winter in Hong Kong, December and April in Gansu, China[@b29], and between September and December in Spain[@b3]. In the current study, a biennial HRV outbreak pattern that occurred during the winter and spring seasons was identified. Chongqing is a subtropical region in China, and the identified seasonal pattern was largely similar to the pattern of influenza that has been identified in other subtropical regions in China (unpublished data). The high circulation pattern in the winter and spring may be explained by meteorological variables, such as temperature, humidity, and precipitation. Further study is warranted to investigate the relationship between meteorological parameters and HRV circulation in other regions. Different but interactive patterns of HRV-A and HRV-C circulation were identified. This temporal pattern of a high HRV-A peak followed by a low HRV-C peak could be attributed to the variation in magnitude of the susceptible population, which considerably diminished following a large outbreak of HRV-A, assuming that a cross protection exists among HRV genotypes.

HRV-C causes significant febrile cough and asthmatic exacerbations in children, thereby requiring hospitalization. Previous studies have reported that HRV-C causes more severe clinical manifestations compared with the other HRV types[@b2][@b18][@b22]. However, in this current study, we only identified an association between HRV-C and an increased development of cough and asthma attacks; no correlation was observed with severe pneumonia. This discrepancy from previous studies could be attributed to the varied recruitment criteria for patients and the impact of a high frequency of co-infection. Considering that the patients in the current study were all hospitalized, they only represented a subset of HRV infections that were more severe than the average. This representation may have suppressed the association between HRV and severe diseases. Nevertheless, the significant associations in this study were inferred after excluding the effects of co-infection by multivariate logistic regression models. This approach presents an advantage over previous studies that lack multivariate analyses for the consideration of the effects from co-infection or other confounding factors[@b1][@b3].

Simmonds et al.[@b30] proposed 13% and 10% divergence thresholds on VP1 nucleotide sequences for type assignment and for identifying different HRV-C types using VP4/VP2. Subsequently, they proposed that the equivalent system for the assignment of new HRV types can be extended to HRV-A and HRV-B[@b31]. In the proposed criteria, the VP4/VP2 sequences are predictive of the HRV species and type, which can be used for type identifications in epidemiological studies. Results from previous studies suggest that most or all HRV-C types circulate freely worldwide, among which HRV-C2, C6, C16, and C43 have higher prevalences than other types[@b31]. VP4/VP2 sequences were used to study the genetic characteristics of HRV-C, and the HRV-C2 genotype was found to be predominant in Chongqing, China. Additionally, some new sequences divergent from the VP4/VP2 sequences were identified in mainland China. Although lacking the complete gene sequences, the available VP4/VP2 sequences logically support the classification of a novel HRV-C2 lineage, confirming the high genetic diversity of HRV-C in the region. Nonetheless, further characterization of the VP1 sequences is necessary for a comprehensive analysis of the novel HRV-C lineage.

In summary, HRV-A and HRV-C were shown to be predominant in HRV infections, with HRV-C displaying a high genetic variation in Chongqing, China. HRV-C infection has been associated with asthma attacks and wheezing occurrence and, to a lesser extent, with severe pneumonia. This knowledge provides information for the prevention and control of HRV-associated ARDs.

Author Contributions
====================

W.C.C. and W.L. conceived and designed this study and revised the manuscripts. Q.B.L., Y.W., L.Y.W., H.Y.W., D.D.H. and X.A.Z. collected the samples and performed the experiments. Q.B.L. and Y.W. analyzed the data and wrote the paper. All authors reviewed the manuscript.

Supplementary Material {#s1}
======================

###### Supplementary Information

Supplementary Table 1 Sequence identity matrix between the sequences from our study and from GenBank

This study is supported by the China Mega-Project on Infectious Disease Prevention (No. 2013ZX10004202) and the National Natural Science Foundation (No. 81222037).

![Phylogenetic analysis of the HRV-C VP4/VP2 coding region using the neighbor-joining method with 1000 bootstrap replicates with MEGA 5.1.\
The branches under the same taxa are labeled by color. The strains in this study are marked with CQ (Chongqing).](srep06686-f1){#f1}

![Composition of HRV-C subtypes in children with ARD.\
The temporally named new subtypes are labeled in red.](srep06686-f2){#f2}

![Monthly detection rate of HRV and subtypes from 2009 to 2012.\
The lines for the HRV, HRV-A, HRV-B, and HRV-C detection rates use the primary y-axis and the histograms for the sample number in every month use the secondary y-axis.](srep06686-f3){#f3}

###### Clinical manifestations and laboratory test results of HRV-infected pediatric patients in Chongqing, China

                                                              HRV           Subtype                                                                   
  ------------------------------------- --------------- --------------- ---------------- ---------- --------------- ---------------- ---------------- --------------------------------------
  Age (month, median)                     8 (1--147)      9 (1--147)       8 (1--145)     0.175^a^    7 (1--147)       6 (1--107)       9 (1--129)                   0.595^a^
  Sex, male (%)                           159 (71.3)       44 (27.9)       114 (72.1)     0.085^b^     82 (67.2)        9 (75.0)        68 (76.4)                    0.429^b^
  Hospitalized duration (day, median)      6 (1--30)       6 (1--20)       6 (1--30)      0.568^a^     6 (1--23)       5 (2--10)        6 (1--30)                    0.331^a^
  Symptoms and signs                                                                                                                                                     
   Cough                                  213 (95.5)       52 (94.6)       161 (95.8)     0.711^b^    115 (94.3)       10 (83.3)        88 (98.9)      0.030^c^[\*](#t1-fn4){ref-type="fn"}
   Expectoration                          171 (76.7)       35 (63.6)       136 (81.0)     0.008^b^     90 (73.8)        9 (75.0)        72 (80.9)                    0.477^c^
   Moist rales                            165 (74.0)       40 (72.7)       124 (73.8)     0.875^b^     91 (74.6)        4 (33.3)        70 (78.7)      0.004^c^[\*](#t1-fn5){ref-type="fn"}
   Rhonchi                                123 (55.2)       25 (45.5)       97 (57.7)      0.112^b^     67 (54.9)        3 (25.0)        53 (59.6)                    0.078^c^
   Diarrhea                                57 (25.6)       7 (12.7)        50 (29.8)      0.012^b^     33 (27.1)        4 (33.3)        20 (22.5)                    0.616^c^
  Laboratory tests (median, range)                                                                                                                                       
   WBC (×10^9^/L)                         11 (4--41)      11 (4--32)       11 (4--41)     0.998^a^    11 (4--32)       12 (6--25)       11 (4--41)                   0.344^a^
   Neutrophils (%)                        39 (10--98)     41 (14--91)     38 (10--98)     0.176^a^    37 (10--93)     36 (20--86)      40 (14--98)                   0.852^a^
   Lymphocytes (%)                        55 (6--89)      53 (6--81)       56 (6--89)     0.196^a^    56 (6--89)      41 (13--71)       56 (6--86)                   0.441^a^
   PLT (×10^9^/L)                        374 (59--689)   348 (59--689)   381 (126--668)   0.348^a^   398 (59--668)   364 (155--527)   391 (126--689)                 0.529^a^
  Co-infection (viruses)                  168 (75.3)          --               --            --        88 (72.1)        9 (75.0)        71 (79.8)                    0.445^c^
  Severe pneumonia                         31 (13.9)       9 (16.4)        22 (13.1)      0.543^b^     20 (16.4)        1 (8.3)         10 (11.2)                    0.479^b^

WBC, white blood cell; HGB, hemoglobin; PLT, platelet.

^&^HRV single infection group compared with HRV co-infection group

^\#^Variables were compared among three HRV subtypes (HRV-A, HRV-B, and HRV-C) by applying nonparametric tests (a), chi--square tests (b), and Fisher\'s exact tests (c).

^\*^HRV subtype pairwise comparison for cough: subtypes A and B (*P* = 0.005), subtypes B and C (*P* = 0.002), and subtypes C and A (*P* = 0.493);

^\*^HRV subtype pairwise comparison for moist rales: subtypes A and B (*P* = 0.186), subtypes B and C (*P* = 0.037), and subtypes C and A (*P* = 0.142).

###### Association between clinical diseases and HRV infection from the multivariate logistic regression

                        Wheezing        Asthma attack   Severe pneumonia                               
  --------------- -------------------- --------------- ------------------- ------- ------------------- -------
  HRV              1.37 (1.020, 1.84)       0.038       1.68 (1.15, 2.45)   0.007   1.00 (0.67, 1.53)   0.988
   Single          1.03 (0.57, 1.88)        0.914       1.66 (1.10, 2.59)   0.176   1.23 (0.57, 2.68)   0.599
   Co-infection    1.45 (1.03, 2.04)        0.033       1.69 (1.10, 2.59)   0.016   0.93 (0.57, 1.52)   0.779
   Negative               1.00                                1.00                        1.00             
  HRV subtype                                                                                              
   HRV-A           1.23 (0.83, 1.82)        0.304       1.68 (1.03, 2.74)   0.038   1.27 (0.75, 2.14)   0.377
   HRV-B           0.45 (0.11, 1.77)        0.253       0.51 (0.06, 4.12)   0.525   0.71 (0.09, 5.75)   0.745
   HRV-C           1.71 (1.08, 2.69)        0.021       1.89 (1.10, 3.27)   0.022   0.73 (0.37, 1.46)   0.374
   Negative               1.00                                1.00                        1.00             

^\*^The logistic regression model was adjusted for the variables of age, sex, duration and the infection of influenza virus, parainfluenza virus, RSV, HAdV, metapneumovirus, HEV, CoV and HBoV.

###### Sequence homology of HRV-C subtypes VP4/VP2 gene sequences

            Maximum sequence homology                       
  -------- --------------------------- -------------------- ----------------
  CQ4290              77.7              HRV-C2 (EF077280)     Named Cpat52
  CQ3144              83.5              HRV-C35 (JF436925)    Named Cpat53
  CQ4245              83.5              HRV-C35 (JF436925)    Named Cpat53
  CQ4260              84.5              HRV-C43 (EU081807)    Named Cpat54
  CQ5641              88.8              HRV-C2 (EF077280)    Belongs to C2
  CQ2026              89.8              HRV-C16 (EU081808)   Belongs to C16
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